nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—Sorafenib—thyroid cancer	0.079	0.32	CbGbCtD
Acebutolol—CYP2D6—Sorafenib—thyroid cancer	0.0745	0.302	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—thyroid cancer	0.0479	0.194	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—thyroid cancer	0.0452	0.183	CbGbCtD
Acebutolol—Mood swings—Sorafenib—thyroid cancer	0.00632	0.00839	CcSEcCtD
Acebutolol—Angiopathy—Vandetanib—thyroid cancer	0.00621	0.00824	CcSEcCtD
Acebutolol—Mediastinal disorder—Vandetanib—thyroid cancer	0.00617	0.00819	CcSEcCtD
Acebutolol—Alopecia—Vandetanib—thyroid cancer	0.00605	0.00803	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.00601	0.00798	CcSEcCtD
Acebutolol—Vision blurred—Vandetanib—thyroid cancer	0.00562	0.00746	CcSEcCtD
Acebutolol—Erectile dysfunction—Sorafenib—thyroid cancer	0.00531	0.00705	CcSEcCtD
Acebutolol—Loss of consciousness—Vandetanib—thyroid cancer	0.00524	0.00695	CcSEcCtD
Acebutolol—Cough—Vandetanib—thyroid cancer	0.0052	0.0069	CcSEcCtD
Acebutolol—Pneumonia—Sorafenib—thyroid cancer	0.00517	0.00687	CcSEcCtD
Acebutolol—Chest pain—Vandetanib—thyroid cancer	0.00507	0.00673	CcSEcCtD
Acebutolol—Arthralgia—Vandetanib—thyroid cancer	0.00507	0.00673	CcSEcCtD
Acebutolol—Anxiety—Vandetanib—thyroid cancer	0.00506	0.00671	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00504	0.00669	CcSEcCtD
Acebutolol—Oedema—Vandetanib—thyroid cancer	0.00486	0.00646	CcSEcCtD
Acebutolol—Nervous system disorder—Vandetanib—thyroid cancer	0.00477	0.00633	CcSEcCtD
Acebutolol—Skin disorder—Vandetanib—thyroid cancer	0.00472	0.00627	CcSEcCtD
Acebutolol—Connective tissue disorder—Sorafenib—thyroid cancer	0.00454	0.00602	CcSEcCtD
Acebutolol—Rash erythematous—Epirubicin—thyroid cancer	0.00444	0.00589	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00443	0.00588	CcSEcCtD
Acebutolol—Insomnia—Vandetanib—thyroid cancer	0.0044	0.00584	CcSEcCtD
Acebutolol—Paraesthesia—Vandetanib—thyroid cancer	0.00437	0.0058	CcSEcCtD
Acebutolol—Dyspnoea—Vandetanib—thyroid cancer	0.00434	0.00576	CcSEcCtD
Acebutolol—Tinnitus—Sorafenib—thyroid cancer	0.00431	0.00572	CcSEcCtD
Acebutolol—Flushing—Sorafenib—thyroid cancer	0.00429	0.00569	CcSEcCtD
Acebutolol—Dyspepsia—Vandetanib—thyroid cancer	0.00428	0.00568	CcSEcCtD
Acebutolol—Decreased appetite—Vandetanib—thyroid cancer	0.00423	0.00561	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0042	0.00557	CcSEcCtD
Acebutolol—Fatigue—Vandetanib—thyroid cancer	0.00419	0.00557	CcSEcCtD
Acebutolol—Angiopathy—Sorafenib—thyroid cancer	0.00419	0.00556	CcSEcCtD
Acebutolol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00416	0.00552	CcSEcCtD
Acebutolol—Pain—Vandetanib—thyroid cancer	0.00416	0.00552	CcSEcCtD
Acebutolol—Constipation—Vandetanib—thyroid cancer	0.00416	0.00552	CcSEcCtD
Acebutolol—Rash erythematous—Doxorubicin—thyroid cancer	0.00411	0.00545	CcSEcCtD
Acebutolol—Alopecia—Sorafenib—thyroid cancer	0.00408	0.00542	CcSEcCtD
Acebutolol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00398	0.00528	CcSEcCtD
Acebutolol—Abdominal pain—Vandetanib—thyroid cancer	0.00385	0.0051	CcSEcCtD
Acebutolol—Body temperature increased—Vandetanib—thyroid cancer	0.00385	0.0051	CcSEcCtD
Acebutolol—Nocturia—Epirubicin—thyroid cancer	0.00366	0.00486	CcSEcCtD
Acebutolol—Syncope—Sorafenib—thyroid cancer	0.00361	0.00479	CcSEcCtD
Acebutolol—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00359	0.00477	CcSEcCtD
Acebutolol—Loss of consciousness—Sorafenib—thyroid cancer	0.00353	0.00469	CcSEcCtD
Acebutolol—Cough—Sorafenib—thyroid cancer	0.00351	0.00466	CcSEcCtD
Acebutolol—Atrioventricular block—Epirubicin—thyroid cancer	0.0035	0.00465	CcSEcCtD
Acebutolol—Asthenia—Vandetanib—thyroid cancer	0.00349	0.00463	CcSEcCtD
Acebutolol—Pruritus—Vandetanib—thyroid cancer	0.00344	0.00457	CcSEcCtD
Acebutolol—Myalgia—Sorafenib—thyroid cancer	0.00342	0.00454	CcSEcCtD
Acebutolol—Arthralgia—Sorafenib—thyroid cancer	0.00342	0.00454	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.0034	0.00451	CcSEcCtD
Acebutolol—Nocturia—Doxorubicin—thyroid cancer	0.00339	0.0045	CcSEcCtD
Acebutolol—Abnormal dreams—Epirubicin—thyroid cancer	0.00336	0.00446	CcSEcCtD
Acebutolol—Diarrhoea—Vandetanib—thyroid cancer	0.00333	0.00442	CcSEcCtD
Acebutolol—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00332	0.00441	CcSEcCtD
Acebutolol—Atrioventricular block—Doxorubicin—thyroid cancer	0.00324	0.0043	CcSEcCtD
Acebutolol—Shock—Sorafenib—thyroid cancer	0.00323	0.00428	CcSEcCtD
Acebutolol—Nervous system disorder—Sorafenib—thyroid cancer	0.00322	0.00427	CcSEcCtD
Acebutolol—Dizziness—Vandetanib—thyroid cancer	0.00322	0.00427	CcSEcCtD
Acebutolol—Skin disorder—Sorafenib—thyroid cancer	0.00319	0.00423	CcSEcCtD
Acebutolol—Dry eye—Epirubicin—thyroid cancer	0.00314	0.00417	CcSEcCtD
Acebutolol—Anorexia—Sorafenib—thyroid cancer	0.00313	0.00415	CcSEcCtD
Acebutolol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00311	0.00413	CcSEcCtD
Acebutolol—Vomiting—Vandetanib—thyroid cancer	0.00309	0.0041	CcSEcCtD
Acebutolol—Rash—Vandetanib—thyroid cancer	0.00307	0.00407	CcSEcCtD
Acebutolol—Dermatitis—Vandetanib—thyroid cancer	0.00306	0.00407	CcSEcCtD
Acebutolol—Headache—Vandetanib—thyroid cancer	0.00305	0.00404	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00299	0.00397	CcSEcCtD
Acebutolol—Abnormal vision—Epirubicin—thyroid cancer	0.00296	0.00393	CcSEcCtD
Acebutolol—Dyspnoea—Sorafenib—thyroid cancer	0.00293	0.00388	CcSEcCtD
Acebutolol—Dry eye—Doxorubicin—thyroid cancer	0.0029	0.00386	CcSEcCtD
Acebutolol—Nausea—Vandetanib—thyroid cancer	0.00289	0.00383	CcSEcCtD
Acebutolol—Dyspepsia—Sorafenib—thyroid cancer	0.00289	0.00383	CcSEcCtD
Acebutolol—Decreased appetite—Sorafenib—thyroid cancer	0.00285	0.00379	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00283	0.00376	CcSEcCtD
Acebutolol—Fatigue—Sorafenib—thyroid cancer	0.00283	0.00375	CcSEcCtD
Acebutolol—Constipation—Sorafenib—thyroid cancer	0.00281	0.00372	CcSEcCtD
Acebutolol—Pain—Sorafenib—thyroid cancer	0.00281	0.00372	CcSEcCtD
Acebutolol—Abnormal vision—Doxorubicin—thyroid cancer	0.00274	0.00364	CcSEcCtD
Acebutolol—Eye pain—Epirubicin—thyroid cancer	0.00273	0.00363	CcSEcCtD
Acebutolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00272	0.00361	CcSEcCtD
Acebutolol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00268	0.00356	CcSEcCtD
Acebutolol—Hot flush—Epirubicin—thyroid cancer	0.00264	0.0035	CcSEcCtD
Acebutolol—Menopausal symptoms—Epirubicin—thyroid cancer	0.00261	0.00347	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00261	0.00347	CcSEcCtD
Acebutolol—Urticaria—Sorafenib—thyroid cancer	0.00261	0.00346	CcSEcCtD
Acebutolol—Abdominal pain—Sorafenib—thyroid cancer	0.00259	0.00344	CcSEcCtD
Acebutolol—Body temperature increased—Sorafenib—thyroid cancer	0.00259	0.00344	CcSEcCtD
Acebutolol—Eye pain—Doxorubicin—thyroid cancer	0.00253	0.00336	CcSEcCtD
Acebutolol—Cardiac failure—Epirubicin—thyroid cancer	0.00253	0.00336	CcSEcCtD
Acebutolol—Lethargy—Epirubicin—thyroid cancer	0.00252	0.00334	CcSEcCtD
Acebutolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00252	0.00334	CcSEcCtD
Acebutolol—Pain in extremity—Epirubicin—thyroid cancer	0.00247	0.00327	CcSEcCtD
Acebutolol—Hot flush—Doxorubicin—thyroid cancer	0.00244	0.00324	CcSEcCtD
Acebutolol—Affect lability—Epirubicin—thyroid cancer	0.00243	0.00322	CcSEcCtD
Acebutolol—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00242	0.00321	CcSEcCtD
Acebutolol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00242	0.00321	CcSEcCtD
Acebutolol—Asthenia—Sorafenib—thyroid cancer	0.00235	0.00312	CcSEcCtD
Acebutolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00234	0.0031	CcSEcCtD
Acebutolol—Mood swings—Epirubicin—thyroid cancer	0.00234	0.0031	CcSEcCtD
Acebutolol—Lethargy—Doxorubicin—thyroid cancer	0.00233	0.00309	CcSEcCtD
Acebutolol—Pruritus—Sorafenib—thyroid cancer	0.00232	0.00308	CcSEcCtD
Acebutolol—Pain in extremity—Doxorubicin—thyroid cancer	0.00228	0.00303	CcSEcCtD
Acebutolol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00225	0.00299	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—thyroid cancer	0.00225	0.00298	CcSEcCtD
Acebutolol—Diarrhoea—Sorafenib—thyroid cancer	0.00224	0.00298	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00222	0.00295	CcSEcCtD
Acebutolol—Dizziness—Sorafenib—thyroid cancer	0.00217	0.00288	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—thyroid cancer	0.00216	0.00287	CcSEcCtD
Acebutolol—Vomiting—Sorafenib—thyroid cancer	0.00209	0.00277	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00208	0.00277	CcSEcCtD
Acebutolol—Rash—Sorafenib—thyroid cancer	0.00207	0.00275	CcSEcCtD
Acebutolol—Dermatitis—Sorafenib—thyroid cancer	0.00207	0.00274	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00206	0.00273	CcSEcCtD
Acebutolol—Headache—Sorafenib—thyroid cancer	0.00206	0.00273	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—thyroid cancer	0.00199	0.00265	CcSEcCtD
Acebutolol—Nausea—Sorafenib—thyroid cancer	0.00195	0.00259	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—thyroid cancer	0.00194	0.00258	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—thyroid cancer	0.00191	0.00254	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—thyroid cancer	0.0019	0.00252	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—thyroid cancer	0.00185	0.00245	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—thyroid cancer	0.00184	0.00245	CcSEcCtD
Acebutolol—Sweating—Epirubicin—thyroid cancer	0.00182	0.00242	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—thyroid cancer	0.0018	0.00238	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—thyroid cancer	0.00177	0.00236	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—thyroid cancer	0.00177	0.00235	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—thyroid cancer	0.00176	0.00234	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—thyroid cancer	0.00174	0.00231	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—thyroid cancer	0.00171	0.00227	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00171	0.00227	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—thyroid cancer	0.0017	0.00225	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—thyroid cancer	0.00169	0.00225	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—thyroid cancer	0.00169	0.00224	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—thyroid cancer	0.00168	0.00223	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—thyroid cancer	0.00164	0.00218	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—thyroid cancer	0.00164	0.00218	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—thyroid cancer	0.00161	0.00213	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—thyroid cancer	0.00159	0.00211	CcSEcCtD
Acebutolol—Flushing—Epirubicin—thyroid cancer	0.00158	0.0021	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—thyroid cancer	0.00158	0.0021	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00157	0.00209	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—thyroid cancer	0.00157	0.00208	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00155	0.00206	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—thyroid cancer	0.00155	0.00206	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00154	0.00204	CcSEcCtD
Acebutolol—Chills—Epirubicin—thyroid cancer	0.00153	0.00203	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—thyroid cancer	0.00152	0.00202	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—thyroid cancer	0.00151	0.002	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—thyroid cancer	0.00147	0.00195	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—thyroid cancer	0.00147	0.00195	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—thyroid cancer	0.00146	0.00194	CcSEcCtD
Acebutolol—Back pain—Epirubicin—thyroid cancer	0.00144	0.00191	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—thyroid cancer	0.00143	0.0019	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00142	0.00189	CcSEcCtD
Acebutolol—Chills—Doxorubicin—thyroid cancer	0.00142	0.00188	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—thyroid cancer	0.0014	0.00186	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—thyroid cancer	0.0014	0.00185	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—thyroid cancer	0.00138	0.00183	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—thyroid cancer	0.00135	0.0018	CcSEcCtD
Acebutolol—Malaise—Epirubicin—thyroid cancer	0.00134	0.00178	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—thyroid cancer	0.00133	0.00177	CcSEcCtD
Acebutolol—Syncope—Epirubicin—thyroid cancer	0.00133	0.00177	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—thyroid cancer	0.00133	0.00177	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—thyroid cancer	0.00131	0.00174	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—thyroid cancer	0.00131	0.00173	CcSEcCtD
Acebutolol—Cough—Epirubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—thyroid cancer	0.0013	0.00172	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00128	0.00169	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—thyroid cancer	0.00126	0.00168	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—thyroid cancer	0.00126	0.00168	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—thyroid cancer	0.00126	0.00168	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—thyroid cancer	0.00126	0.00167	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00126	0.00167	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—thyroid cancer	0.00125	0.00166	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—thyroid cancer	0.00124	0.00165	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—thyroid cancer	0.00124	0.00164	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—thyroid cancer	0.00123	0.00164	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—thyroid cancer	0.00122	0.00162	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—thyroid cancer	0.00121	0.00161	CcSEcCtD
Acebutolol—Oedema—Epirubicin—thyroid cancer	0.00121	0.00161	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.00121	0.0016	CcSEcCtD
Acebutolol—Cough—Doxorubicin—thyroid cancer	0.0012	0.00159	CcSEcCtD
Acebutolol—Shock—Epirubicin—thyroid cancer	0.00119	0.00158	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—thyroid cancer	0.00119	0.00158	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—thyroid cancer	0.00118	0.00156	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.00117	0.00156	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—thyroid cancer	0.00117	0.00155	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—thyroid cancer	0.00117	0.00155	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—thyroid cancer	0.00117	0.00155	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—thyroid cancer	0.00117	0.00155	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00116	0.00154	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—thyroid cancer	0.00116	0.00153	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—thyroid cancer	0.00113	0.0015	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—thyroid cancer	0.00113	0.0015	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—thyroid cancer	0.00112	0.00149	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.0011	0.00147	CcSEcCtD
Acebutolol—Shock—Doxorubicin—thyroid cancer	0.0011	0.00147	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.0011	0.00146	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—thyroid cancer	0.0011	0.00146	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—thyroid cancer	0.00109	0.00145	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—thyroid cancer	0.00109	0.00145	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00108	0.00144	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—thyroid cancer	0.00108	0.00143	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—thyroid cancer	0.00108	0.00143	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—thyroid cancer	0.00107	0.00142	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—thyroid cancer	0.00107	0.00142	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—thyroid cancer	0.00105	0.0014	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—thyroid cancer	0.00105	0.00139	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00105	0.00139	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—thyroid cancer	0.00105	0.00139	CcSEcCtD
Acebutolol—Pain—Epirubicin—thyroid cancer	0.00104	0.00138	CcSEcCtD
Acebutolol—Constipation—Epirubicin—thyroid cancer	0.00104	0.00138	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00102	0.00136	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—thyroid cancer	0.00101	0.00135	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—thyroid cancer	0.00101	0.00134	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—thyroid cancer	0.001	0.00133	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—thyroid cancer	0.000999	0.00133	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—thyroid cancer	0.000997	0.00132	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000992	0.00132	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—thyroid cancer	0.000988	0.00131	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—thyroid cancer	0.000975	0.00129	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000969	0.00129	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—thyroid cancer	0.000967	0.00128	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—thyroid cancer	0.000963	0.00128	CcSEcCtD
Acebutolol—Pain—Doxorubicin—thyroid cancer	0.000959	0.00127	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—thyroid cancer	0.000959	0.00127	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—thyroid cancer	0.000959	0.00127	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—thyroid cancer	0.000959	0.00127	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000925	0.00123	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000917	0.00122	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—thyroid cancer	0.000891	0.00118	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—thyroid cancer	0.000887	0.00118	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—thyroid cancer	0.000887	0.00118	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—thyroid cancer	0.00087	0.00115	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—thyroid cancer	0.000858	0.00114	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—thyroid cancer	0.00083	0.0011	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—thyroid cancer	0.000805	0.00107	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—thyroid cancer	0.000802	0.00106	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—thyroid cancer	0.000794	0.00105	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—thyroid cancer	0.000771	0.00102	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—thyroid cancer	0.000768	0.00102	CcSEcCtD
Acebutolol—Rash—Epirubicin—thyroid cancer	0.000765	0.00101	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—thyroid cancer	0.000764	0.00101	CcSEcCtD
Acebutolol—Headache—Epirubicin—thyroid cancer	0.00076	0.00101	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—thyroid cancer	0.000742	0.000985	CcSEcCtD
Acebutolol—Nausea—Epirubicin—thyroid cancer	0.00072	0.000956	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—thyroid cancer	0.000713	0.000947	CcSEcCtD
Acebutolol—Rash—Doxorubicin—thyroid cancer	0.000707	0.000939	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—thyroid cancer	0.000707	0.000938	CcSEcCtD
Acebutolol—Headache—Doxorubicin—thyroid cancer	0.000703	0.000933	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—thyroid cancer	0.000666	0.000885	CcSEcCtD
